World News Australia - Drug companies turn to 'Pharma 2.0'

via sbs.com.au

But coming up next, Ernst & Young argues, is "Pharma 3.0," in which pharmaceutical companies will increasingly look to sell ancillary products and services linked to their medicines by working with IT and other companies.

Posted via web from Jack's posterous